| 5-HT | serotonin |
| 5-HTRs | serotonin receptors |
| aa | amino acids |
| AA | arachidonic acid |
| AADE | arachidonic acid-derived eicosanoids |
| AC | adenylyl cyclase |
| ACh | acetylcholine |
| AD | Alzheimer’s disease |
| ADHD | attention-deficit/hyperactivity disorder |
| AP-1 | activator protein 1 |
| APCs | antigen-presenting cells |
| ARRB2 | arrestin beta-2, also known as beta-arrestin-2 |
| ASD | autism spectrum disorders |
| BBB | blood–brain barrier |
| bFGF | basic fibroblast growth factor |
| cAMP | cyclic 3′,5′ adenosine monophosphate |
| CBM | CBM signalosome complex = CARD11 (the caspase recruitment domain family member 11)—BCL10 (B cell CLL/lymphoma 10)—MALT1 (mucosa associated lymphoid tissue lymphoma translocation protein 1) paracaspase |
| c-fos | protooncogene (human homolog of the retroviral oncogene v-fos) |
| cGMP | cyclic guanosine monophosphate |
| CNS | central nervous system |
| CREB | cAMP-responsive element-binding protein |
| CSF | cerebrospinal fluid |
| DA | dopamine |
| DAG | diacylglycerol |
| DAO | diamine oxidase |
| DCs | dendritic cells |
| ECL cells | enterochromaffin-like cells |
| ECs | endothelial cells |
| eNOS | endothelial nitric oxide synthase |
| ERS | endoplasmic reticulum stress |
| GABA | γ-amino butyric acid |
| GDP | guanosine diphosphate |
| GLU | glutamate |
| GTP | guanosine triphosphate |
| GPCRs | G protein-coupled receptors, also known as the seven-(pass)-transmembrane (7TM) domain receptors |
| H1R, H2R, H3R, H4R | four histamine receptors, respectively |
| HA | histamine |
| HD | Huntington’s disease |
| HDC | enzyme L-histidine decarboxylase |
| HMT | histamine N-methyltransferase, also known as HNMT |
| IAA | imidazole acetic acid |
| IAA-RP | imidazole acetic acid ribotide |
| ID | intellectual disability |
| IFG | inferior frontal gyrus |
| IFN-γ | interferon gamma |
| IL-1β, IL-10, IL-12, IL-33 | interleukins: 1 beta, 10, 12, and 33, respectively |
| IP3 | inositol 1,4,5-trisphosphate |
| KD | dissociation constant |
| LBs | Lewy bodies |
| MAO-B | monoamine oxidase B |
| MAPK | mitogen-activated protein kinase |
| MCH | melanin-concentrating hormone |
| MCs | mast cells |
| MDD | major depressive disorder |
| NA | norepinephrine |
| NMD | neurodevelopmental motor disorders |
| NSCs | neural stem cells |
| NSD | narcolepsy spectrum disorder |
| NF-κβ | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NK cells | natural killer cells |
| NMDA | N-methyl-D-aspartate |
| NO | nitric oxide |
| NREM | non-rapid eye movement phase of sleep |
| Nτ-MH | tele-methylhistamine |
| OCPD | obsessive–compulsive personality disorder |
| OCT3 | organic cation transporter 3 |
| PD | Parkinson’s disease |
| PFC | prefrontal cortex |
| PIP2 | phosphatidylinositol 4,5-bisphosphate |
| PKA | protein kinase A |
| PKC | protein kinase C |
| PLA2 | phospholipase A2 |
| PLC | phospholipase C |
| PLD | phospholipase D |
| PMAT | plasma membrane monoamine transporter |
| REM | rapid eye movement phase of sleep |
| ROS | reactive oxygen species |
| Schiz | schizophrenia |
| SDAT | senile dementia of the Alzheimer’s disease type |
| SNP | single-nucleotide polymorphism |
| TGFβ | transforming growth factor beta |
| Th1, Th2 | Type 1 T helper and type 2 T helper cells, respectively |
| t-MIAA | tele-methylimidazole acetic acid |
| TMN | tuberomammillary nucleus |
| TNFα | tumor necrosis factor alpha |
| TRAF6 | tumor necrosis factor (TNF) receptor-associated factor 6 |
| VEGF | vascular endothelial growth factor |
| VMAT2 | vesicular monoamine transporter |
| VSMCs | vascular smooth muscle cells |
| XO | xanthine oxidase |